These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38982006)

  • 1. Pharmacokinetics and Histotoxic Profile of a Novel Azithromycin-Loaded Lipid-Based Nanoformulation.
    Rahman AU; Khan M; Khan MA; Rehman MU; Abdullah ; Ahmed S
    AAPS PharmSciTech; 2024 Jul; 25(6):157. PubMed ID: 38982006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amorphous azithromycin with improved aqueous solubility and intestinal membrane permeability.
    Aucamp M; Odendaal R; Liebenberg W; Hamman J
    Drug Dev Ind Pharm; 2015; 41(7):1100-8. PubMed ID: 24980913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encapsulation of Azithromycin Ion Pair in Liposome for Enhancing Ocular Delivery and Therapeutic Efficacy on Dry Eye.
    Ren T; Lin X; Zhang Q; You D; Liu X; Tao X; Gou J; Zhang Y; Yin T; He H; Tang X
    Mol Pharm; 2018 Nov; 15(11):4862-4871. PubMed ID: 30251864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin.
    Chandra R; Liu P; Breen JD; Fisher J; Xie C; LaBadie R; Benner RJ; Benincosa LJ; Sharma A
    Clin Pharmacokinet; 2007; 46(3):247-59. PubMed ID: 17328583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerosol-based efficient delivery of azithromycin to alveolar macrophages for treatment of respiratory infections.
    Togami K; Chono S; Morimoto K
    Pharm Dev Technol; 2013; 18(6):1361-5. PubMed ID: 22812381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of oral azithromycin in epididymal tissue.
    Sadahira T; Wada K; Ikawa K; Morikawa N; Mitsui M; Araki M; Fujiyoshi M; Ishii A; Watanabe M; Watanabe T; Nasu Y
    J Infect Chemother; 2019 Oct; 25(10):832-834. PubMed ID: 31255523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on rectal administration of azithromycin by suppository for pediatric use.
    Maeda M; Nakano Y; Aoyama T; Matsumoto Y; Fujito H
    Int J Clin Pharmacol Ther; 2016 Apr; 54(4):263-8. PubMed ID: 26833461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative plasma exposure and lung distribution of two human use commercial azithromycin formulations assessed in murine model: a preclinical study.
    Rivulgo V; Sparo M; Ceci M; Fumuso E; Confalonieri A; Delpech G; Bruni SF
    Biomed Res Int; 2013; 2013():392010. PubMed ID: 24073402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of a single dose of sustained-release azithromycin formulation in pigeons.
    Zań R; Burmańczuk A; Stępień-Pyśniak D; Gajda A; Gbylik-Sikorska M; Posyniak A; Kowalski C; Grabowski T
    Pol J Vet Sci; 2020 Mar; 23(1):43-50. PubMed ID: 32233287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic and clinical studies with azithromycin (capsule) in the pediatric field. Pediatric Study Group of Azithromycin].
    Fujii R; Abe T; Tajima T; Terashima I; Meguro H; Sunakawa K; Yokota T; Akita H; Iwata S; Takeuchi Y
    Jpn J Antibiot; 1995 Sep; 48(9):1074-92. PubMed ID: 7474330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Sustained Release Azithromycin Resinate Fabricated by One-Pot Ion-exchange Performed in Hydro-alcoholic Solution.
    Liang H; Zhao M; Wang S; Wang D; Gou J; Bai Y; Shen M; Wang J; Cheng Y; Ge N; Zhao Y; Zeng J; Sun L; Xu H
    AAPS PharmSciTech; 2024 Sep; 25(7):226. PubMed ID: 39327374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive biodegradable nanoparticles-in-nanofibers single-dose ocular insert: in vitro, ex vivo and in vivo evaluation.
    Khalil IA; Ali IH; El-Sherbiny IM
    Nanomedicine (Lond); 2019 Jan; 14(1):33-55. PubMed ID: 30543484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical development and optimization of azithromycin suppository for paediatric use.
    Kauss T; Gaubert A; Boyer C; Ba BB; Manse M; Massip S; Léger JM; Fawaz F; Lembege M; Boiron JM; Lafarge X; Lindegardh N; White NJ; Olliaro P; Millet P; Gaudin K
    Int J Pharm; 2013 Jan; 441(1-2):218-26. PubMed ID: 23220079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic Evaluation of Improved Oral Bioavailability of Valsartan: Proliposomes Versus Self-Nanoemulsifying Drug Delivery System.
    Nekkanti V; Wang Z; Betageri GV
    AAPS PharmSciTech; 2016 Aug; 17(4):851-62. PubMed ID: 26381913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy:
    Abd-Elhakeem E; El-Nabarawi M; Shamma R
    Drug Deliv; 2021 Dec; 28(1):642-654. PubMed ID: 33787445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetic and clinical studies with azithromycin (fine granule) in the pediatric field. Pediatric Study Group of Azithromycin].
    Tajima T; Kobayashi M; Terashima I; Meguro H; Sunakawa K; Yokota T; Akita H; Iwata S; Takeuchi Y; Fujii R
    Jpn J Antibiot; 1995 Sep; 48(9):1051-73. PubMed ID: 7474329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetic and relative bioavailability study of coated and uncoated azithromycin powder for suspension in healthy Bangladeshi male volunteers.
    Sultana TA; Islam MS; Bhuiyan NH; Shohag MH; Ahmed MU; Naznin SR; Al Maruf A; Huq SM; Hasnat A
    Arzneimittelforschung; 2011; 61(10):594-8. PubMed ID: 22164968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular surface distribution and pharmacokinetics of a novel ophthalmic 1% azithromycin formulation.
    Akpek EK; Vittitow J; Verhoeven RS; Brubaker K; Amar T; Powell KD; Boyer JL; Crean C
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):433-9. PubMed ID: 19857105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipine.
    Nekkanti V; Rueda J; Wang Z; Betageri GV
    Int J Pharm; 2016 May; 505(1-2):79-88. PubMed ID: 27041124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanostructured Lipid Carriers for Oral Bioavailability Enhancement of Exemestane: Formulation Design, In Vitro, Ex Vivo, and In Vivo Studies.
    Singh A; Neupane YR; Mangla B; Kohli K
    J Pharm Sci; 2019 Oct; 108(10):3382-3395. PubMed ID: 31201904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.